IMMUNOGEN, INC.

Patent Owner

Follow Compare Add to Portfolio 6Status Updates

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
 
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 105147
 
 
 
C07K PEPTIDES 6261
 
 
 
C07D HETEROCYCLIC COMPOUNDS 5292
 
 
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 10179
 
 
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 885
 
 
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 595
 
 
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 450
 
 
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 4150
 
 
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 290
 
 
 
B01D SEPARATION 1128

Top Patents (by citation)

Upgrade to the Premium Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2016/0272,616 METHODS FOR THE PREPARATION OF CHARGED CROSSLINKERSDec 15, 15Sep 22, 16[C07D]
2016/0263,238 NOVEL MAYTANSINOID DERIVATIVES WITH PEPTIDE LINKER AND CONJUGATES THEREOFFeb 09, 16Sep 15, 16[C07D, A61K, C07K]
2016/0222,013 NOVEL BENZODIAZEPINE DERIVATIVESJan 07, 16Aug 04, 16[C07D]
2016/0146,824 Diagnostic Assays and Kits for Detection of Folate Receptor 1Oct 23, 15May 26, 16[A61K, G01N, C07K]
2016/0137,604 PURIFICATION OF INTERMEDIATES USED IN THE PREPARATION OF HETEROBIFUNCTIONAL LINKERSJun 26, 14May 19, 16[C07D]
2016/0114,052 POTENT CONJUGATES AND HYDROPHILIC LINKERSAug 25, 15Apr 28, 16[A61K]
2016/0115,238 CD20 Antibodies and Uses ThereofSep 16, 15Apr 28, 16[A61K, C07K]
2016/0108,126 CD20 Antibodies and Uses ThereofSep 16, 15Apr 21, 16[A61K, C07K]
2016/0095,938 CONJUGATES COMPRISING CELL-BINDING AGENTS AND CYTOTOXIC AGENTSSep 02, 15Apr 07, 16[A61K, C07K]
2016/0096,887 Folate Receptor 1 Antibodies and Immunoconjugates and Uses ThereofDec 15, 15Apr 07, 16[A61K, C07K]

View all Publication..

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9,446,146 Methods and agents for improving targeting of CD138 expressing tumor cellsDec 23, 08Sep 20, 16[A61K, C07K]
9,447,189 CD37-binding molecules and immunoconjugates thereofMar 30, 12Sep 20, 16[C12N, A61K, C07K]
9,434,748 Cytotoxic benzodiazepine derivativesSep 09, 15Sep 06, 16[C07D, A61K, C07K]
9,428,543 Preparation of maytansinoid antibody conjugates by a one-step processJun 24, 14Aug 30, 16[A61K, C07K]
9,387,261 Immunoconjugates targeting CD138 and uses thereofDec 23, 08Jul 12, 16[A61K]
9,381,256 Cytotoxic benzodiazepine derivativesSep 02, 15Jul 05, 16[C07D, A61K]
9,375,488 Compounds to fibroblast growth factor receptor-3 (FGFR3) and methods of treatmentDec 11, 14Jun 28, 16[G01N, A61K]
9,376,500 Conjugation methodsDec 03, 13Jun 28, 16[C07D, A61K, C07K]
9,370,584 CA6 antigen-specific cytotoxic conjugate and methods of using the sameOct 26, 10Jun 21, 16[A61K, C07K]
9,359,442 Anti-CD33 antibodies and methods for treatment of acute myeloid leukemia using the sameApr 10, 14Jun 07, 16[A61K, C07K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2015/0297,744 Anti-FOLR1 Immunoconjugate Dosing RegimensABANMar 27, 15Oct 22, 15[A61K, C07K]
2015/0110,816 METHODS OF TREATMENT USING ANTI-ERBB ANTIBODY-MAYTANSINOID CONJUGATESABANJun 04, 14Apr 23, 15[A61K, C07K]
2014/0212,411 METHODS OF TREATMENT USING ANTI-ERBB ANTIBODY-MAYTANSINOID CONJUGATESABANSep 19, 13Jul 31, 14[A61K]
2014/0093,523 Anti-Integrin Immunoconjugates, Methods and UsesABANDec 04, 13Apr 03, 14[A61K]
2013/0295,050 ANTI-IGF-I RECEPTOR ANTIBODIES, DNAS, VECTORS, HOST CELLS AND GENETIC CONSTRUCTSABANSep 14, 12Nov 07, 13[A61K]
2013/0108,620 METHODS OF TREATMENT USING ANTI-ERBB ANTIBODY-MAYTANSINOID CONJUGATESABANNov 28, 11May 02, 13[A61K]
2012/0282,282 Methods for Decreasing Ocular Toxicity of Antibody Drug ConjugatesABANApr 04, 12Nov 08, 12[A61P, A61K]
2012/0269,827 Compositions and Methods for Treatment of Ovarian, Peritoneal, and Fallopian Tube CancerABANMar 29, 12Oct 25, 12[A61P, A61K]
2012/0259,100 PROCESS FOR MANUFACTURING CONJUGATES OF IMPROVED HOMOGENEITYABANMar 29, 12Oct 11, 12[C07K]
2012/0226,025 METHOD OF TARGETING SPECIFIC CELL POPULATIONS USING CELL-BINDING AGENT MAYTANSINOID CONJUGATES LINKED VIA A NON-CLEAVABLE LINKER, SAID CONJUGATES AND METHODS OF MAKING SAID CONJUGATESABANMay 11, 12Sep 06, 12[C07K]
2012/0226,026 POTENT CONJUGATES AND HYDROPHILIC LINKERSABANMay 17, 12Sep 06, 12[C07D, C07K]
8,137,669 Elimination of heterogeneous or mixed cell population in tumorsExpiredAug 05, 08Mar 20, 12[A61K]
8,093,358 Methods of treatment using anti-erbb antibody-maytansinoid conjugatesWithdrawnDec 03, 07Jan 10, 12[C07K]
2011/0300,162 DRUG CONJUGATE COMPOSITIONABANAug 18, 11Dec 08, 11[A61B, A61P, A61K]
2011/0280,890 PRODRUGS OF CC-1065 ANALOGSABANJul 15, 11Nov 17, 11[C07D, A61P, A61K, C07K]
8,034,904 Anti-IGF-I receptor antibodyExpiredDec 08, 03Oct 11, 11[C12P]
8,012,978 Prodrugs of CC-A1065 analogsExpiredSep 04, 08Sep 06, 11[C07F, A61K]
7,985,842 Anti-IGF-I receptor antibodyExpiredNov 24, 08Jul 26, 11[C07H, C12P, G01N, A61K, C07K]
2011/0177,064 Compositions and Methods for Treatment of Ovarian CancerABANJan 21, 11Jul 21, 11[A61P, A61K]
2011/0166,319 PROCESS FOR PREPARING PURIFIED DRUG CONJUGATESABANDec 22, 10Jul 07, 11[C07K]

View all patents..

Top Inventors for This Owner

Upgrade to the Premium Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.